CDC Guidelines for STI Testing and Prophylaxis After Sexual Assault
Baseline Evaluation
- Baseline testing is primarily for documentation, not definitive exclusion of infection, because pathogens may be undetectable immediately after exposure. The CDC notes that early tests serve as a reference point while awaiting seroconversion or pathogen proliferation. 1
- Specimens should be collected from every site of penetration or attempted penetration (genital, rectal, pharyngeal) based on exposure history, including:
- A serum sample should be preserved at the initial visit for later testing if follow‑up serologies become positive, allowing determination of whether infection preceded the assault. 1
Follow‑Up Testing Schedule
- If prophylactic antimicrobial treatment was not administered, repeat bacterial STI testing (gonorrhea, chlamydia, trichomoniasis) at 2 weeks to capture infections that were initially below detection thresholds. 1
- Final HIV and syphilis serology at 6 months post‑assault is required to definitively exclude infection acquired during the assault, as seroconversion may be delayed. 2
HIV Post‑Exposure Prophylaxis (nPEP)
- nPEP should be considered within 72 hours when the assailant is known to be HIV‑positive or when the exposure is deemed substantial (vaginal, rectal, or ocular). The CDC recommends prompt initiation to reduce transmission risk. [2][3]
- Decision‑making for nPEP includes:
- For pediatric victims, a specialist in pediatric HIV should be consulted to select age‑appropriate nPEP dosing and management. [2][4]
Counseling and Prevention
- Patients should be advised to use condoms for any sexual activity until the prophylactic regimen is completed and repeat testing confirms the absence of infection. This reduces the risk of transmitting any undetected STI. 1
All facts are derived from CDC recommendations as published in the MMWR Recommendations and Reports (1993 and 2015). No explicit strength of evidence was provided in the source documents.
Post-Sexual Assault Testing and Follow-Up Protocol
Immediate Management
- The Centers for Disease Control and Prevention recommends routine prophylactic antimicrobial therapy after sexual assault, including Ceftriaxone 125 mg IM, Metronidazole 2 g orally, and Azithromycin 1 g orally or Doxycycline 100 mg orally twice daily for 7 days, to prevent potential complications and provide psychological reassurance in patients who have been sexually assaulted 5, 6
- Hepatitis B vaccination should be initiated immediately if the patient is not already vaccinated or immune based on serology, with a 3-dose series at 0, 1-2 months, and 4-6 months, as recommended by the Centers for Disease Control and Prevention 5, 6
Mandatory Follow-Up Testing Schedule
- The Centers for Disease Control and Prevention recommends repeat testing for chlamydia, gonorrhea, and trichomonas at 2 weeks, and repeat HIV and syphilis serology at 6 weeks, 3 months, and 6 months after the assault, to ensure detection of infections that may not have been detectable at the initial examination 5, 6, 7, 8
- Repeat HIV and syphilis serology at 3 months and 6 months after the assault is critical because HIV antibody seroconversion may not be detectable until 3 months post-exposure, and syphilis serologic tests require 6-12 weeks to become positive after infection 5, 6, 8
Pregnancy Considerations
- A urine pregnancy test should be performed at baseline and repeated at 2 weeks if the patient's period is late, as recommended by the American Academy of Pediatrics 8
Critical Counseling Points
- Patients should be educated on the window period for infections, including bacterial STIs, HIV, and syphilis, and advised to abstain from sexual activity until 7 days after completing prophylactic treatment or until repeat testing confirms no infection, as recommended by the Centers for Disease Control and Prevention 9, 10, 8
- Referral to a Sexual Assault Referral Centre or equivalent counseling services should be strongly encouraged as part of standard care, as recommended by the American Academy of Pediatrics 8